Kala Pharmaceuticals Inc
F:27F
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kala Pharmaceuticals Inc
F:27F
|
US |
|
Titan SA
F:TCJ
|
BE |
|
V
|
Value Valves Co Ltd
TPEX:4580
|
TW |
|
B
|
Bpost SA
XMUN:13B
|
BE |
|
Richter Gedeon Vegyeszeti Gyar Nyrt
F:RIG2
|
HU |
|
T
|
TRG Pakistan Ltd
KAR:TRG
|
PK |
|
Persol Holdings Co Ltd
OTC:TEMPF
|
JP |
|
A
|
AGFA Gevaert NV
XMUN:AGE
|
BE |
|
K
|
Krakatau Steel (Persero) Tbk PT
XMUN:07K
|
ID |
|
D
|
DNI Beteiligungen AG
XMUN:DN1
|
DE |
Dividends
Dividend Yield
Kala Pharmaceuticals Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Kala Pharmaceuticals Inc
27F have decreased by 0%.
Payout Ratio
Kala Pharmaceuticals Inc
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for 27F is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
27F Price
Kala Pharmaceuticals Inc
| Average Annual Return | -79.29% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -91% |
| Market Capitalization | 7.4m EUR |
| Shares Outstanding | 72 594 005 |
| Percentage of Shares Shorted |
N/A
|
